Insulet’s first chief technology officer leaves company
Photo | Courtesy of Insulet
Mark Field
Just shy of two years after a C-suite reorganization at Insulet, Mark Field has left his position as the inaugural chief technology officer at the Acton medical device manufacturer.
Field, who also served as the firm’s senior vice president, stepped away from his positions on Friday to pursue other opportunities. He was immediately succeeded in an interim capacity by Amit Guliani, Insulet’s group vice president, software engineering, according to a Monday filing with the U.S. Securities and Exchange Commission.
Guliani will serve as chief technology officer while Insulet initiates a search for Field’s permanent replacement.
Insulet did not return WBJ’s request for comment.
Field joined Insulet in 2019 as group vice president, according to his LinkedIn profile. He assumed the company’s first chief technology officer position in 2023. Prior to Insulet, Field served in the same C-suite role at Thermo Fisher Scientific, a Waltham-based medical device company.
In October, Insulet received $1.92 million as part of a state tax incentive program to develop 110 manufacturing positions, including engineering and quality technician jobs and those in sales and marketing; research and development; and customer support.
In December, the firm was awarded $452 million in total damages after a federal jury found its South Korean-based competitor EOFlow guilty for misappropriating Insulet trade secrets.
Mica Kanner-Mascolo is a staff writer at Worcester Business Journal, who primarily covers the healthcare and diversity, equity, and inclusion industries.
WBJ Web Partners
Most Recent
Most Recent
0 Comments